Jing Li

8254862, Aug 28, 2012

Dec 29, 2009

12/649006

Dan B. Kasha - Seattle WA, US
Jing Li - Austin TX, US
Russell Croman - Austin TX, US
Michael Johnson - Austin TX, US
Scott D. Willingham - Austin TX, US

Silicon Laboratories Inc. - Austin TX

H04B 1/18

4551501, 455333, 455334

In one embodiment, the present invention includes a single chip radio tuner, which may be adapted within an integrated circuit (IC). The tuner may be provided with a configurable front end to receive and process a radio frequency (RF) signal via a signal path. This configurable front end may be differently controlled depending on a particular radio implementation in which the tuner is adapted.

8463215, Jun 11, 2013

Dec 29, 2009

12/649011

Dan B. Kasha - Seattle WA, US
Jing Li - Austin TX, US
Russell Croman - Austin TX, US
Michael Johnson - Austin TX, US
Scott D. Willingham - Austin TX, US

Silicon Laboratories Inc. - Austin TX

H04B 1/18

4551501, 455333, 455334

In one embodiment, the present invention includes a method for configuring a single chip radio tuner having a configurable front end, which may be adapted within an integrated circuit (IC). The method may include setting a controller of the tuner with configuration information for a radio in which the tuner is located. Then, control signals responsive to the configuration information can be sent to the configurable front end to configure the tuner.

20030032027, Feb 13, 2003

Feb 12, 2002

10/073123

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US

C12Q001/68
G06F019/00
A61K048/00

435/006000, 702/020000, 514/044000

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the WIP1 gene, which are amplified breast, and/or lung, and/or colon, and/or ovarian, and/or prostate cancer genes. The WIP1 gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

20030044814, Mar 6, 2003

Feb 8, 2002

10/071838

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Phil Xiang - San Francisco CA, US
Yue Peng - South Setauket NY, US

Tularik Inc. - South San Francisco CA

C12Q001/68
G01N033/574
C12P019/34

435/006000, 435/007230, 435/091200

The present invention provides nucleic acid and protein sequences for a novel protein, PRC17, and methods, reagents, and kits for diagnosing and treating cancer in a mammal, e.g., a human. This invention is based upon the discovery that the novel PRC17 is overexpressed and/or amplified in cancer. Methods to detect cancer or a propensity to develop cancer, to monitor the efficacy of a cancer treatment, and to treat cancer, by inhibiting the expression and/or activity of PRC17 in a cancer cell are included.

20030099985, May 29, 2003

Aug 27, 2002

10/228263

Jing Li - Flushing NY, US

C12Q001/68
G06F019/00
G01N033/48
G01N033/50
A61K048/00

435/006000, 702/020000, 514/044000

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the C8FW gene, which are amplified breast and/or brain and/or colon and/or lung and/or prostate and/or ovarian cancer genes. The C8FW gene, its expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they are also used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

20040005596, Jan 8, 2004

Mar 18, 2003

10/390191

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Jianxin Yang - Commack NY, US

C12Q001/68
G01N033/574
C07H021/04
A61K048/00

435/006000, 514/044000, 536/023200, 435/007230

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the CTSZ and CD24 genes, which are amplified colon cancer and/or ovarian cancer and/or breast cancer genes. The CTSZ and CD24 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or vaccine; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

20040005615, Jan 8, 2004

May 22, 2003

10/443108

Jing Li - Flushing NY, US
David Mu - Jericho NY, US
Jianxin Yang - Commack NY, US

C12Q001/68
C07H021/04
C12P021/02
C12N005/06
A61K048/00
C07K014/705

435/006000, 435/069100, 435/320100, 435/325000, 530/350000, 514/044000, 536/023500

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing the RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, which are amplified in many types of cancer. The RecQL5, CTXL, USP13, MCL1, and Pellino1 genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.

20040171037, Sep 2, 2004

Nov 18, 2003

10/715117

Jing Li - Flushing NY, US
Scott Powers - Greenlawn NY, US
Wun Sin - Dix Hills NY, US
Jianxin Yang - Commack NY, US

C12Q001/68
A61K048/00

435/006000, 514/044000

There are disclosed methods and compositions for the diagnosis, prevention, and treatment of tumors and cancers in mammals, for example, humans, utilizing genes, which are amplified in many types of cancer. The amplified genes, their expressed protein products and antibodies are used diagnostically or as targets for cancer therapy or as vaccines; they also are used to identify compounds and reagents useful in cancer diagnosis, prevention, and therapy.